AngelCentral
VC Fund
AngelCentral is a VC fund focused on Software and E-Commerce. AngelCentral empowers angels in Southeast Asia with quality deal flow, syndication services, and lots of learning. It organizes regular curated pitch sessions, angel education workshops, and provides syndication services. The idea for AngelCentral started in late 2016 as a community initiative by the Partners to share their personal experiences andlessons learned on angel investing.
- Total investments:
- 27
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries AngelCentral invests in
Stages AngelCentral invests in
Countries AngelCentral invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $614k–$3.3M
- Pre-Seed
- $220k–$600k
- Series A
- $1.5M–$5M
Investment Focus
Industry
- Software 6 (22%)
- E-Commerce 3 (11%)
- Real Estate 3 (11%)
- Property Management 3 (11%)
- Information Technology 3 (11%)
Stage
- Seed 10 (37%)
- Series A 4 (15%)
- Pre-Seed 2 (7%)
- Funding Round 2 (7%)
Country
- Singapore 9 (33%)
- Thailand 2 (7%)
- Indonesia 2 (7%)
- Vietnam 1 (4%)
- Malaysia 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Patrick Poirier
Seraph Member
|
Seraph Member | Total investments: 0 | Find email | |
Teck Moh Phey
Partner and Cofounder
|
Partner and Cofounder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Rybodyn
|
Rybodyn is a biotechnology research company that develops therapeutics to train the immune system to detect and eradicate cancer internally. | Seed / Jul 23, 2026 | |
H3 Zoom.AI
|
H3 Zoom is an AI-powered inspection intelligence platform focused on the built environment, helping organizations assess and manage buildings and critical infrastructure. It processes visual and sensor data from drones, 360° cameras, robotics, and other capture tools to generate structured inspection insights. The platform uses AI to detect,classify, and localize defects while assigning severity levels based on engineering and regulatory standards. It produces audit-ready reports and remediation recommendations designed to support maintenance planning and compliance workflows. | $3.6M / Series A / Jun 22, 2026 | |
PharmInt
|
A fully integrated B2B Pharmaceutical Products MarketplaceAt Pharmint, we bring together everything that’s required to procure pharma products globally under one roof. We help suppliers get discovered, negotiate prices, and seal the trade terms whereas we help our buyers by vetting all documentation and holding their payments in escrow till theirshipments are delivered and verified.A technology first approach to solving counter-party risk Experience true peace of mind as a buyer as we do the heavy lifting for you. Get access to thousands of verified sellers from across the world while our trade and escrow services ensure that your purchases are protected.Get the best prices & selection of products Our vast network of over 500 verified and onboarded suppliers with a catalogue of over 10,000 products ensures we serve all buyer needs across various MOQ and pricing banHow it works:From product discovery to product deliveryWe assist you in discovering new products, matching with potential qualified manufacturers, and making the deals happen.1. Discover new productsSearch for the high-potential products in the largest human-curated CTD database. Narrow your search applying the industry-specific filter that helps sort products by GMP approvals, country of origin, dossier type, dossier status, stability, and other valuable features.2. Get offers from manufacturers3. Connect with qualified manufacturers directlyThe largest database Simplify product discovery, reduce business development effort and costs with access to an expert curated up-to-date CTD dossier database.Direct supplier relations We enjoy direct working relations with platform manufacturers. We’ll provide the best conditions to negotiate your deal details and use our authority to make the deal happen.Vetted products We match customers only with qualified manufacturers. Our marketplace features only vetted products with up-to-date regulatory data.Industry expertise Pharmint is backed by in-depth understanding of the pharmaceutical market by its founders and associates and a strong track-record in the pharmaceutical industry.Commercial guidance We assist our customers in preparing the deal structure, evaluate annual forecasts and pricing, regulatory requirements and cover other aspects in bringing new products to market.Self-service 24/7 Buyers can search for products, make multiple RFQs, receive commercial offers, negotiate deals and build their pipeline. Sellers can manage an unlimited number of products and indicate market availability at any time. | $1M / Seed / Oct 05, 2024 | |
Ailytics
|
Ailytics is the leading video analytics company in SEA that helps companies enhance safety and productivity for their operations. We specialize in the construction industry but can also transfer our technology into other industries. | $2.7M / Seed / Apr 01, 2024 | |
Motorist
|
Motorist is a comprehensive AutoConcierge platform that helps drivers conveniently manage all aspects of vehicle ownership and vehicle transactions. | Series A / Jan 22, 2024 | |
Meiro CDP
|
At Meiro we build Customer Data Platform so the business can maximize the value of their first party, customer-related data by creating golden record of a customer and drive personalization from there. | $3M / Seed / Jan 16, 2024 | |
Blood
|
Blood (previously known as pslove) is a consumer product start-up on a mission to end “period slavery” – the times when you feel like a slave to your period and it completely overcomes you. We invented MenstruHeat, the #1 menstrual cramp relief patch in the region with more than 1 million cramps relieved across 15 countries. We selldirect-to-consumer, as well as through leading retailers. | $2.5M / Series A / Jan 01, 2024 | |
Bizhare
|
Bizhare is a business investment company that offers equity crowdfunding services. | Nov 21, 2023 | |
|
Bizhare
|
Bizhare is a business investment company that offers equity crowdfunding services. | Seed / Nov 21, 2023 | |
|
Blood
|
Blood (previously known as pslove) is a consumer product start-up on a mission to end “period slavery” – the times when you feel like a slave to your period and it completely overcomes you. We invented MenstruHeat, the #1 menstrual cramp relief patch in the region with more than 1 million cramps relieved across 15 countries. We selldirect-to-consumer, as well as through leading retailers. | $1.5M / Series A / May 26, 2023 | |
| See all 27 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does AngelCentral invest in?
AngelCentral invests primarily in Software, E-Commerce and Real Estate startups, most often at Seed and Series A stage. Most of the 27 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is AngelCentral's check size?
AngelCentral typically joins rounds of $614k–$3.3M at Seed, $220k–$600k at Pre-Seed and $1.5M–$5M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds AngelCentral participates in.
How do I contact AngelCentral?
Public channels for AngelCentral include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at AngelCentral?
The team at AngelCentral includes Patrick Poirier (Seraph Member) and Teck Moh Phey (Partner and Cofounder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
